Cooperative Agreement NU51PS005195

Award Date 9/30/21
Completion Date 9/29/26
Dollars Obligated $3.2M
Funding Federal Agency
National Center for HIV/AIDS
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.940
Assistance Type
Cooperative Agreement
Place of Performance
Washington, DC, USA
Similar Awards
This Cooperative Agreement award of $2,400,000, provided by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), supports the National Alliance of State & Territorial AIDS Directors (NASTAD) in establishing a Syndemic Technical Assistance Center (SYNTAC). The SYNTAC will provide capacity building assistance to strengthen the infectious disease public health workforce's ability to respond to the...
The National Institute on Drug Abuse (NIDA) awarded a $707,647 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Weill Medical College of Cornell University to conduct research on universal hepatitis C virus (HCV) screening during pregnancy. The project aims to: 1) determine if revised HCV testing guidelines led to increased testing rates among pregnant women compared to non-pregnant women; 2) assess if the guidelines increased postpartum HCV linkage to care, treatment,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is aimed at implementing a low-threshold Hepatitis C (HCV) treatment strategy in a jail setting. The $252,042 award, effective September 15, 2024, will support a pilot study at Rhode Island Hospital to evaluate the feasibility and effectiveness of the "MINMON-J" approach, which modifies a minimal monitoring HCV treatment protocol for use...
The Alaska Native Tribal Health Consortium (ANTHC) was awarded a $3,544,875 cooperative agreement from the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The award, titled "Ending the HIV/HCV/Syphilis Epidemics in Indian Country II (ETHIC II)," aims to address the disproportionately high rates of HIV, hepatitis C (HCV), and syphilis affecting...
This Project Grant award, totaling $2,150,000, was provided by the Health Resources and Services Administration (HRSA) under the HIV Emergency Relief Project Grants program (CFDA 93.914). The National Alliance of State & Territorial AIDS Directors (NASTAD), a non-profit organization based in Washington, DC, will use the funding to support HRSA and its HRSA-25-063 recipients in response to HRSA-25-065: Ending the HIV Epidemic: A Plan for America - Systems Coordination Provider (EHE SCP)....
The National Center for HIV/AIDS awarded a $1,200,000 Cooperative Agreement to Matthew 25 AIDS Services, Inc. under the HIV Prevention Activities Health Department Based program (CFDA 93.940). This five-year project aims to enhance sexual health in rural Kentucky by accelerating clinical testing, prevention, and care for sexually transmitted infections (STIs), establishing a mobile sexual health clinic, and collaborating with community partners to deliver effective prevention, care, and...
This Cooperative Agreement award from the National Center for HIV/AIDS, part of the Centers for Disease Control and Prevention (CDC), provides $742,220 in funding to the Massachusetts Department of Public Health (MDPH) to support the Massachusetts STI Surveillance Network. The goals of this 5-year project are to: (1) expand and improve STI surveillance data to develop a stronger knowledge base of STI trends and social determinants; (2) guide the development of tailored, evidence-based public...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, aims to develop a low-cost, rapid antigen test for active hepatitis C virus (HCV) infection. The total funding amount is $272,133, with an award date of June 18, 2025 and an ultimate completion date of May 31, 2027. The project will characterize the binding kinetics of HCV core antigen-specific monoclonal antibodies and use the...
The Health Services Kentucky Cabinet For was awarded a $11,263,403 Cooperative Agreement by the National Center for HIV/AIDS (CFDA 93.940 - HIV Prevention Activities Health Department Based) to implement high-impact HIV prevention and surveillance programs across Kentucky over a 5-year period from August 2024 to May 2029. The project will align core HIV prevention, Ending the HIV Epidemic, surveillance, and Ryan White services to achieve goals outlined in the National HIV/AIDS Strategy...
The City of Houston, through its Health and Human Services Division, was awarded a $49,480,881 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The award will fund enhanced and innovative high-impact HIV surveillance and prevention activities in the Houston metropolitan area from August 1, 2024 to May 31, 2029. Key activities include: (1) increasing and expanding HIV testing through...

HEPATITIS NETWORK FOR EDUCATION AND TESTING (HEPNET)TO IMPROVE HEPATITIS OUTCOMES FOR PEOPLE WHO USE DRUGS - NASTAD?S PROJECT ABSTRACT SUMMARY FOR NATIONAL VIRAL HEPATITIS EDUCATION, AWARENESS, AND CAPACITY BUILDING FOR COMMUNITIES AND PROVIDERS (CDC-RFA-PS21-2105)?PART A: COMMUNITY EDUCATION, AWARENESS, AND CAPACITY BUILDING THE HEPATITIS NETWORK FOR EDUCATION AND TESTING (HEPNET) IS A CONSORTIUM OF PUBLIC HEALTH PARTNERS, COMMUNITY-BASED ORGANIZATIONS, PEOPLE WITH LIVED EXPERIENCE, AND HEALTHCARE PROVIDERS, FOCUSED ON IDENTIFYING AND ADDRESSING THE UNMET NEEDS OF PEOPLE WHO INJECT DRUGS (PWID) TO IMPROVE THEIR ACCESS TO VIRAL HEPATITIS EDUCATION, PREVENTION, TESTING, LINKAGE TO CARE, AND TREATMENT. OVER THE LAST FIVE YEARS, THE NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORS (NASTAD) ESTABLISHED AND HAS SUCCESSFULLY OPERATED THE HEPATITIS TESTING PARTNERSHIP AND LEARNING COLLABORATIVE UNDER THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) COOPERATIVE AGREEMENT?VIRAL HEPATITIS NETWORKING, CAPACITY BUILDING, AND TRAINING (CDC-RFA- PS16-1608). THE FIVE-YEAR AWARD HAS SIGNIFICANTLY CHANGED THE LANDSCAPE FOR NATIONAL SUPPORT AND COORDINATION TO IMPROVE VIRAL HEPATITIS TESTING. THE VAST COALITION AND LEARNING COMMUNITY ESTABLISHED THROUGH THE HEPATITIS TESTING PARTNERSHIP AND LEARNING COLLABORATIVE IS THE FOUNDATION FROM WHICH NASTAD AND ITS PARTNERS, THE NATIONAL ASSOCIATION OF CITY AND COUNTY HEALTH OFFICIALS (NACCHO) AND THE NATIONAL VIRAL HEPATITIS ROUNDTABLE (NVHR), PROPOSE TO FORM A NEW EXPANDED COALITION DEDICATED TO ADVANCING HEPATITIS B AND HEPATITIS C TESTING AND LINKAGE TO CARE FOR PWID. HEPNET WILL ALIGN AND MOBILIZE NASTAD, NACCHO, AND NVHR?S EXISTING HEPATITIS COALITIONS ACROSS STATE AND LOCAL HEALTH DEPARTMENTS, COMMUNITY-BASED ORGANIZATIONS (CBOS), PATIENTS AND CLINICAL PROVIDERS, AND OTHER KEY PARTNERS TO ESTABLISH A CONSORTIUM OF OVER 100 MEMBER ORGANIZATIONS. THE PROJECT IS IMPLEMENTED THOUGH THREE MAIN STRATEGIES: NETWORKING AND COALITION ENHANCEMENT?LEADING, MAINTAINING, AND GROWING THE PRIMARY PARTNERS? EXISTING NATIONA L COALITIONS AND NETWORKS TO SHARE RESOURCES, STRATEGIES AND MODELS TO IMPROVE ACCESS AND DELIVERY OF VIRAL HEPATITIS SERVICES TO PWID; CAPACITY BUILDING ? PROVIDING TECHNICAL ASSISTANCE AND TRAINING TO SELECTED HEPNET MEMBERS TO DELIVER CULTURALLY-RESPONSIVE VIRAL HEPATITIS EDUCATIONAL OUTREACH TO PWID AND BUILD THEIR CAPACITY TO CONDUCT VIRAL HEPATITIS TESTING AMONG PWID OF DIVERSE BACKGROUNDS AND EXPERIENCES; AND CAMPAIGN IMPLEMENTATION?INCREASING THE REACH OF AND EXPOSURE TO CDC?S NATIONAL EDUCATION VIRAL HEPATITIS CAMPAIGN MATERIALS THROUGH PROMOTION TO AND BY HEPNET?S MEMBERS. THE PROJECT WORK PLAN DETAILS SPECIFIC, MEASURABLE, AND TIME-PHASED OBJECTIVES DESIGNED TO SUPPORT ONGOING EVALUATION OF THE FIVE-YEAR PROJECT. EVALUATION FINDINGS WILL BE USED FOR CONTINUOUS PROGRAM QUALITY IMPROVEMENT TO IMPROVE HEPATITIS OUTCOMES FOR PWID OF DIVERSE BACKGROUNDS AND EXPERIENCES.

Posted 7/30/21, 12:00 AM